ArticleClinical and experimental vaccine research2026
Temporal dynamics of IgM and IgG after COVID-19 vaccination: a pilot cohort study on breakthrough infections.
Article in Clinical and experimental vaccine research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: During the coronavirus disease 2019 (COVID-19) pandemic, we conducted a cohort study analyzing changes in immunoglobulin (Ig) M and IgG antibody levels before and after COVID-19 vaccination. Methods: The study compared two groups: participants who were infected with severe acute respiratory syndrome coronavirus 2 within 14 days of vaccination and those who were not. We evaluated dynamic changes in IgM and IgG levels immediately following vaccination and assessed their potential correlation with infection risk. Results: Participants who contracted COVID-19 within 14 days of vaccination exhibited significantly higher IgM antibody levels than uninfected individuals, likely due to combined stimulation by both the vaccine and the virus. In the infected group, IgG antibody levels were lower than those in the uninfected group during the first 1 to 5 days post-vaccination. Moreover, across all participants, IgG antibody levels were generally lower than baseline during the first 1 to 3 days post-vaccination. Conclusions: These findings suggest that, in the early stages following vaccination, the immune system may experience a temporary "immune trough," potentially even below pre-vaccination levels. As a result, individuals should exercise additional caution during this period to mitigate infection risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.